Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 12 of 13, showing 5 Applications out of 62 total, starting on record 56, ending on 60

# Protocol No Study Title Investigator(s) & Site(s)

56.

ECCT/18/06/01   Safety, Acceptability, and Feasibility of enterade® (SAFE)
    Safety, Acceptability, and Feasibility of enterade® in children at risk for environmental enteric dysfunction in Kakamega County, Kenya   
Principal Investigator(s)
1. Michael Benjamin Arndt
2. James Mukabi
Site(s) in Kenya
Kakamega County General Hospital (CGH)
 
View

57.

ECCT/20/11/02   IAVI C100
    Safety and Pharmacokinetics of the Combination Broadly Neutralizing  Antibodies, 3BNC117-LS-J and 10-1074-LS-J, in Healthy American and   African Adults (IAVI C100)   
Principal Investigator(s)
1. Nelly Mugo
Site(s) in Kenya
1. Partners in Health Research and Development (PHRD) – CCR-KEMRI (Kiambu county)
2. Kenya AIDS Vaccine Initiative- Institute of Clinical Research (KAVI-ICR) (Nairobi City county)
 
View

58.

ECCT/20/07/02   RV 460 HIV Vaccine Trial
    A Randomized, Double-Blind Phase 1 Trial to Evaluate the Safety and Immunogenicity of   Priming with Env-C Plasmid DNA Vaccine Alone, with Different Adjuvants, or with an   Adjuvanted HIV Env gp145 C.6980 Protein Vaccine and Boosting with the Adjuvanted   HIV Env gp145 C.6980 Protein Vaccine with or without the Env-C Plasmid DNA Vaccine   in Healthy HIV Uninfected Adults in Kenya   
Principal Investigator(s)
1. Josphat Kosgei
Site(s) in Kenya
KEMRI/US MRDA-A/K, KERICHO
 
View

59.

ECCT/23/09/02   CROSSWALK Acute (A)
    A PHASE IB, RANDOMIZED, PLACEBO-CONTROLLED STUDY EVALUATING THE SAFETY, PHARMACOKINETICS, PHARMACODYNAMICS, AND EFFICACY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO‑OCCLUSIVE EPISODES (VOE) IN PATIENTS WITH SICKLE CELL DISEASE (SCD)   
Principal Investigator(s)
1. Doreen Terry Karimi
Site(s) in Kenya
Gertrudes Childrens Hospital
 
View

60.

ECCT/22/09/03   SINGLE DOSE VERSUS EXTENDED DO
    EFFECTIVENESS OFSINGLE-DOSE ANTIBIOTIC USE IN ELECTIVE CAESAREANSECTION IN PREVENTION OF SURGICAL SITE INFECTION AT JARAMOGI    OGINGA ODINGA TEACHING AND REFERRAL HOSPITAL, KISUMU COUNTY,KENYA: A RANDOMIZED CONTROL TRIAL.   
Principal Investigator(s)
1. STEVEN ODHIAMBO JUMA
Site(s) in Kenya
JARAMOGI OGINGA ODINGA TEACHING AND REFERRAL HOSPITAL
 
View